We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
-12.87%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$13.9B
AUM Growth
-$8.15B
Cap. Flow
-$5.52B
Cap. Flow %
-39.78%
Top 10 Hldgs %
10.16%
Holding
2,006
New
392
Increased
427
Reduced
517
Closed
664

Top Buys

Rank Stock Value
1
DLTR icon
Dollar Tree
DLTR
+$107M
2
CB icon
Chubb
CB
+$107M
3
FITB
Fifth Third Bancorp
FITB
+$91.9M
4
DOC icon
Healthpeak Properties
DOC
+$90.9M
5
AMZN icon
Amazon
AMZN
+$86.9M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$150M
2
CNP icon
CenterPoint Energy
CNP
+$133M
3
EFX icon
Equifax
EFX
+$132M
4
RTX icon
RTX Corp
RTX
+$110M
5
RF icon
Regions Financial
RF
+$107M

Sector Composition

Rank Sector Weight
1 Financials 19.16%
2 Consumer Discretionary 12.71%
3 Real Estate 9.83%
4 Healthcare 9.38%
5 Technology 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADNT icon
1351
Adient
ADNT
$1.46B
-15,365
Closed -$604K
ADUS icon
1352
Addus HomeCare
ADUS
$2.24B
-33,093
Closed -$2.32M
AEIS icon
1353
Advanced Energy
AEIS
$13B
-4,837
Closed -$250K
AG icon
1354
First Majestic Silver
AG
$9.28B
-150,000
Closed -$852K
AGNC icon
1355
PUT
AGNC Investment
AGNC
$12.8B
-50,000
Closed -$936K
AHT
1356
Ashford Hospitality Trust
AHT
$20.7M
-387
Closed -$2.44M
AIN icon
1357
Albany International
AIN
$1.75B
-15,813
Closed -$1.26M
AKAM icon
1358
CALL
Akamai
AKAM
$17B
-187,500
Closed -$13.8M
ALKS icon
1359
PUT
Alkermes
ALKS
$8.17B
-200,000
Closed -$7.92M
ALNY icon
1360
Alnylam Pharmaceuticals
ALNY
$29.3B
-10,046
Closed -$879K
ALNY icon
1361
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
-194,000
Closed -$18.4M
AM icon
1362
Antero Midstream
AM
$10.3B
-13,200
Closed -$223K
AMAL icon
1363
Amalgamated Financial
AMAL
$1.49B
-103,785
Closed -$2M
AMAT icon
1364
CALL
Applied Materials
AMAT
$424B
-131,200
Closed -$5.12M
AMED
1365
PUT
DELISTED
Amedisys
AMED
-30,000
Closed -$3.54M
AMRN
1366
Amarin Corp
AMRN
$302M
-70,709
Closed -$25.8M
AMZN icon
1367
PUT
Amazon
AMZN
$3T
-1,858,000
Closed -$186M
ANAB icon
1368
CALL
AnaptysBio
ANAB
$1.67B
-20,000
Closed -$1.8M
ANAB icon
1369
AnaptysBio
ANAB
$1.67B
-88,957
Closed -$8.88M
AON icon
1370
Aon
AON
$75.9B
-3,483
Closed -$536K
APLS
1371
DELISTED
Apellis Pharmaceuticals
APLS
-60,000
Closed -$1.07M
APPF icon
1372
AppFolio
APPF
$7B
-12,039
Closed -$944K
AR icon
1373
Antero Resources
AR
$11.1B
-40,020
Closed -$709K
ARCB icon
1374
ArcBest
ARCB
$3.08B
-7,805
Closed -$379K
ARE icon
1375
Alexandria Real Estate Equities
ARE
$8.35B
-718,452
Closed -$90.4M

Similar funds

Balyasny Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Balyasny Asset Management held 2,006 positions worth $13.9B, down 37% from $22B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Balyasny Asset Management withdrew a net $5.52B in Q4 2018, closing 664 positions and reducing 517 holdings. Its most notable exit was Equifax, an estimated $132M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Real Estate.

Against the trend, Balyasny Asset Management opened a new position in Aflac worth $83M.

  • Balyasny Asset Management's largest Q4 2018 buy was Aflac: 1,821,849 shares worth $83M.
  • Balyasny Asset Management added most to Dollar Tree in Q4 2018, an estimated $107M increase.
  • Balyasny Asset Management's biggest Q4 2018 reduction was Wells Fargo, cutting an estimated $150M.
  • Balyasny Asset Management fully exited Equifax in Q4 2018, selling an estimated $132M.
  • Balyasny Asset Management's ten largest holdings make up 10% of its $13.9B portfolio in Q4 2018.
  • Balyasny Asset Management opened 392 new positions and closed 664 in Q4 2018.
  • Balyasny Asset Management's portfolio value fell 37% quarter-over-quarter to $13.9B.

Based on Balyasny Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.